Manganese-iron layered double hydroxide: a theranostic nanoplatform with pH-responsive MRI contrast enhancement and drug release.

Stimuli-responsive theranostic platforms are highly desirable for efficient cancer treatment because of their improved specificity and sensitivity. In this work, we report a manganese-iron layered double hydroxide (MnFe-LDH) for the first time and demonstrate that it can serve as a pH-responsive nanoplatform for cancer theranostics. The MnFe-LDH can respond to the acidic microenvironment of solid tumors to release paramagnetic Mn2+ and Fe3+ ions, resulting in great enhancement of the T1 MRI contrast of the tumor area. In addition, the layered structure enables MnFe-LDH to effectively deliver chemotherapeutic drugs in a pH-controlled manner, and therefore it can simultaneously inhibit the growth of solid tumors. We believe that this novel MnFe-LDH with pH-responsive property holds great promise in cancer theranostic applications.

[1]  Sung Tae Kim,et al.  Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. , 2007, Angewandte Chemie.

[2]  Yanqing Hua,et al.  A Gd-doped Mg-Al-LDH/Au nanocomposite for CT/MR bimodal imagings and simultaneous drug delivery. , 2013, Biomaterials.

[3]  Enzo Terreno,et al.  Image guided therapy: the advent of theranostic agents. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Wenxiu Zhao,et al.  Engineered iron-oxide-based nanoparticles as enhanced T1 contrast agents for efficient tumor imaging. , 2013, ACS nano.

[5]  Inhan Lee,et al.  Surface Modification of Exfoliated Layered Gadolinium Hydroxide for the Development of Multimodal Contrast Agents for MRI and Fluorescence Imaging , 2009 .

[6]  Mingyuan Gao,et al.  In vivo covalent cross-linking of photon-converted rare-earth nanostructures for tumour localization and theranostics , 2016, Nature Communications.

[7]  Hui Li,et al.  Facile integration of multiple magnetite nanoparticles for theranostics combining efficient MRI and thermal therapy. , 2015, Nanoscale.

[8]  Dermot O'Hare,et al.  Recent advances in the synthesis and application of layered double hydroxide (LDH) nanosheets. , 2012, Chemical reviews.

[9]  Xiaomin Wang,et al.  Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control. , 2014, Nanoscale.

[10]  Huang-Hao Yang,et al.  Gadolinium oxysulfide-coated gold nanorods with improved stability and dual-modal magnetic resonance/photoacoustic imaging contrast enhancement for cancer theranostics. , 2017, Nanoscale.

[11]  X. Duan,et al.  Layered double hydroxide films: synthesis, properties and applications. , 2010, Chemical communications.

[12]  Huang-Hao Yang,et al.  Co9Se8 Nanoplates as a New Theranostic Platform for Photoacoustic/Magnetic Resonance Dual‐Modal‐Imaging‐Guided Chemo‐Photothermal Combination Therapy , 2015, Advanced materials.

[13]  Sanjiv S Gambhir,et al.  A molecular imaging primer: modalities, imaging agents, and applications. , 2012, Physiological reviews.

[14]  P. Chou,et al.  Antiferromagnetic iron nanocolloids: a new generation in vivo T1 MRI contrast agent. , 2013, Journal of the American Chemical Society.

[15]  Juan Li,et al.  Plant Polyphenol-Assisted Green Synthesis of Hollow CoPt Alloy Nanoparticles for Dual-Modality Imaging Guided Photothermal Therapy. , 2016, Small.

[16]  Jun‐Jie Zhu,et al.  Nanomaterial-based activatable imaging probes: from design to biological applications. , 2015, Chemical Society reviews.

[17]  Chengjie Sun,et al.  A multiple gadolinium complex decorated fullerene as a highly sensitive T(1) contrast agent. , 2015, Chemical communications.

[18]  Kemin Wang,et al.  A pH-responsive activatable aptamer probe for targeted cancer imaging based on i-motif-driven conformation alteration , 2016, Science China Chemistry.

[19]  Zijian Zhou,et al.  Highly magnetic iron carbide nanoparticles as effective T(2) contrast agents. , 2014, Nanoscale.

[20]  Taeghwan Hyeon,et al.  Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents. , 2011, Journal of the American Chemical Society.

[21]  Zipeng Zhen,et al.  Gd‐Encapsulated Carbonaceous Dots with Efficient Renal Clearance for Magnetic Resonance Imaging , 2014, Advanced materials.

[22]  Andrew Tsourkas,et al.  Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent. , 2010, Angewandte Chemie.

[23]  Yongmin Chang,et al.  Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images. , 2009, ACS nano.

[24]  Huang-Hao Yang,et al.  Multifunctional Fe₃O₄@polydopamine core-shell nanocomposites for intracellular mRNA detection and imaging-guided photothermal therapy. , 2014, ACS nano.

[25]  Ki Young Choi,et al.  Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. , 2012, Nanoscale.

[26]  Z. Yin,et al.  Real-time monitoring of arsenic trioxide release and delivery by activatable T(1) imaging. , 2015, ACS nano.

[27]  Vicente Rives,et al.  Intercalation of drugs in layered double hydroxides and their controlled release: A review , 2014 .

[28]  R. Kankala,et al.  Layered double hydroxide nanoparticles for biomedical applications: Current status and recent prospects , 2015 .

[29]  Y. Zhao,et al.  Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes. , 2012, Nanoscale.

[30]  Ying Liu,et al.  Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. , 2011, Small.

[31]  R. Reilly,et al.  What nephrologists need to know about gadolinium , 2007, Nature Clinical Practice Nephrology.

[32]  J. Atherton,et al.  Hierarchical layered double hydroxide nanocomposites: structure, synthesis and applications. , 2015, Chemical communications.